Cardiovascular Drugs and Therapy

, Volume 21, Issue 2, pp 77–79

Cerebrovascular Events After Discontinuation of Rofecoxib Treatment

Authors

    • Charité—Universitaetsmedizin BerlinInstitute of Clinical Pharmacology and Toxicology
Editorial

DOI: 10.1007/s10557-007-6022-6

Cite this article as:
Andersohn, F. Cardiovasc Drugs Ther (2007) 21: 77. doi:10.1007/s10557-007-6022-6

Copyright information

© Springer Science+Business Media, LLC 2007